American Association of Individual Investors

Why Lexicon Pharmaceuticals, Inc.’s (LXRX) Stock Is Down 13.64%

As of Friday, November 07, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 13.64%, which has investors ...
American Association of Individual Investors

Why Eton Pharmaceuticals, Inc.’s (ETON) Stock Is Down 12.23%

As of Friday, November 07, Eton Pharmaceuticals, Inc.’s ETON share price has dipped by 12.23%, which has investors questioning if this is right time to buy.

Stock Split Watch: Could This Unstoppable Growth Stock Be Next?

However, the Eli Lilly has roared back and is up 32% year to date. The stock price now exceeds $1,000, which could ...

Sun Pharma Share Price Highlights: Sun Pharma Stock Price History

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Sudeep Pharma IPO opens today: Issue price, GMP, price band, allotment and more

Shares of Sudeep Pharma are trading at a 19% premium in the unlisted market, with the current grey market premium (GMP) of ...

Sun Pharma Share Price Live Updates: Sun Pharma's 3-Month Return Highlights

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

OLMA stock: could today’s 197% surge be just the beginning?

OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...
The Financial Express

Is this Pharma stock set for a comeback? Here’s why Motilal Oswal sees as much as 17% upside

Motilal Oswal has given Gland Pharma a ‘Buy’ rating with a Rs 2,310 target price, implying a 17% upside. The brokerage expects strong growth ahead, driven by new product launches, facility upgrades, ...